MedTrace Logo

Air Optix® Night and Day® Aqua Continuous Wear

NCT05992675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1256

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this retrospective, Post-Market Clinical Follow-Up (PMCF) study is to assess the long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn as 30 days of continuous wear for vision correction.

Conditions

  • Refractive Errors

Interventions

DEVICE

Lotrafilcon A contact lenses

CE-marked silicone hydrogel contact lenses

DEVICE

Balafilcon A contact lenses

CE-marked silicone hydrogel contact lenses

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, CRD Vision Care · Alcon Research, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-05
Primary Completion
2024-08-22
Completion
2024-08-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05992675 on ClinicalTrials.gov